SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-028738
Filing Date
2020-12-17
Accepted
2020-12-17 16:57:22
Documents
4
Period of Report
2021-01-26
Effectiveness Date
2020-12-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10017450x4_def14a.htm DEF 14A 240033
2 logo_mackenzie3.jpg GRAPHIC 20552
3 nc10017450x4_pc01.jpg GRAPHIC 514037
4 nc10017450x4_pc02.jpg GRAPHIC 425090
  Complete submission text file 0001140361-20-028738.txt   1561975
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38022 | Film No.: 201396752
SIC: 2834 Pharmaceutical Preparations